Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Candas

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
International Journal of Radiation Oncology, Biology, Physics|January 15, 1997
Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancerJ Laverdière, J L Gomez, L Cusan, et al.
The Prostate|February 11, 1999
Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trialF Labrie, B Candas, A Dupont, et al.
The Prostate|August 29, 2000
Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancerB Candas, L Cusan, J L Gomez, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|December 1, 1993
Optimized strategy for detection of early stage, curable prostate cancer: role of prescreening with prostate-specific antigenF Labrie, A Dupont, R Suburu, et al.
Urology|March 1, 1997
Neoadjuvant hormonal therapy: the Canadian experienceF Labrie, L Cusan, J L Gomez, et al.
The American Journal of Surgical Pathology|January 1, 1996
Effect of neoadjuvant endocrine therapy (combined androgen blockade) on normal prostate and prostatic carcinoma. A randomized studyL Vailancourt, B Ttu, Y Fradet, et al.
Advances in Protein Chemistry|May 2, 2001
Pure selective estrogen receptor modulators, new molecules having absolute cell specificity ranging from pure antiestrogenic to complete estrogen-like activitiesF Labrie, C Labrie, A Bélanger, et al.
Current Oncology (Toronto, Ont.)|October 25, 2013
Hereditary colorectal cancer registries in Canada: report from the Colorectal Cancer Association of Canada consensus meeting; Montreal, Quebec; October 28, 2011H Rothenmund, H Singh, B Candas, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 27, 1999
EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometriumF Labrie, C Labrie, A Bélanger, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
International Journal of Radiation Oncology, Biology, Physics|January 15, 1997
Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancerJ Laverdière, J L Gomez, L Cusan, et al.
The Prostate|February 11, 1999
Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trialF Labrie, B Candas, A Dupont, et al.
The Prostate|August 29, 2000
Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancerB Candas, L Cusan, J L Gomez, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|December 1, 1993
Optimized strategy for detection of early stage, curable prostate cancer: role of prescreening with prostate-specific antigenF Labrie, A Dupont, R Suburu, et al.
Urology|March 1, 1997
Neoadjuvant hormonal therapy: the Canadian experienceF Labrie, L Cusan, J L Gomez, et al.
The American Journal of Surgical Pathology|January 1, 1996
Effect of neoadjuvant endocrine therapy (combined androgen blockade) on normal prostate and prostatic carcinoma. A randomized studyL Vailancourt, B Ttu, Y Fradet, et al.
Advances in Protein Chemistry|May 2, 2001
Pure selective estrogen receptor modulators, new molecules having absolute cell specificity ranging from pure antiestrogenic to complete estrogen-like activitiesF Labrie, C Labrie, A Bélanger, et al.
Current Oncology (Toronto, Ont.)|October 25, 2013
Hereditary colorectal cancer registries in Canada: report from the Colorectal Cancer Association of Canada consensus meeting; Montreal, Quebec; October 28, 2011H Rothenmund, H Singh, B Candas, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 27, 1999
EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometriumF Labrie, C Labrie, A Bélanger, et al.
Pageof 4